Projects

Evaluation of cfDNA and inflammatory markers in risk stratification of young adults for metabolic syndrome

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Dr Jaya Kumari S

Authors

Dr Jayakumari S, Dr Jyothi D N, Dr Jyothi Prabhu, Dr Ganapathi Bantwal, Dr Deepthi Shanbhag, Dr Tinku Thomas

Project Status

ongoing

Project Type

PI Initiated Study